Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-20-001286
Filing Date
2020-05-21
Accepted
2020-05-21 20:27:29
Documents
1
Period of Report
2020-05-11

Document Format Files

Seq Description Document Type Size
1 form3-05212020_050515.html 3  
1 form3-05212020_050515.xml 3 4080
  Complete submission text file 0001415889-20-001286.txt   5418
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
KING STEVEN W (Reporting) CIK: 0001244106 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21990 | Film No.: 20903426